MedTrace Logo

Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis

NCT02345096 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2016-12-05

No results posted yet for this study

Summary

This study aims to evaluate the effect of a specific strain of Saccharomyces cerevisiae on improving the effectiveness of conventional treatment of vulvo-vaginal candidiasis. This is a randomized, double-blind, placebo-controlled study.

Conditions

  • Vulvo-vaginal Candidiasis

Interventions

DIETARY_SUPPLEMENT

Saccharomyces cerevisiae

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Eurofins Optimed

    collaborator INDUSTRY

  • Lesaffre International

    lead INDUSTRY

Principal Investigators

  • Robert Cherbut, MD · Independant gynecologist

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-06-30
Completion
2016-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02345096 on ClinicalTrials.gov